MannKind Stock Income Statements

MannKind Quarterly Income Statements Chart

Quarterly

Annual

Operating Profit

Net Income

MannKind Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-02-14	2010-02-14	2010-02-14	2009-02-14	2009-02-14	2008-02-14	2008-02-14	2007-02-14	2007-02-14	2006-02-14	2006-02-14	2005-02-14	2005-02-14	2004-09-30	2004-06-30	2004-02-14

revenues:
commercial product sales	22,454,000	18,973,000
collaborations and services	22,845,000	29,376,000
royalties	31,228,000	30,005,000											304,000
total revenues	76,527,000	78,354,000	76,776,000	70,079,000	72,386,000	66,263,000	58,472,000	51,253,000	48,611,000	40,626,000	36,059,000	32,825,000	18,894,000	11,992,000	12,515,000	22,211,000	23,280,000	17,436,000	18,443,000	15,352,000	15,114,000	16,235,000	15,993,000	14,595,000	15,002,000	17,448,000	16,032,000	4,469,000	3,893,000	3,465,000	4,530,000	2,043,000	2,163,000	3,009,000
expenses:
cost of goods sold – commercial	4,607,000	3,768,000
cost of revenue – collaborations and services	15,961,000	13,748,000	14,796,000	14,826,000	14,772,000	14,779,000	11,953,000	10,259,000	9,013,000	10,683,000
research and development	13,675,000	11,022,000	11,138,000	12,926,000	11,816,000	10,013,000	9,236,000	9,989,000	6,453,000	5,605,000	7,156,000	4,136,000	4,893,000	3,536,000	3,886,000	3,655,000	2,329,000	2,442,000	1,545,000	1,484,000	1,464,000	1,755,000	2,021,000	1,580,000	1,632,000	1,667,000	1,084,000	2,043,000	2,967,000	2,644,000	3,507,000	4,361,000	3,123,000	3,129,000	1,560,000	3,917,000	4,310,000	5,130,000	6,219,000	6,341,000	7,737,000	9,377,000	17,560,000	19,178,000	37,323,000	26,182,000	1,496,561,000	27,281,000	27,052,000	26,398,000	1,391,326,000	25,453,000	26,638,000	24,156,000	1,286,334,000	23,132,000	1,292,381,000	1,241,875,000	1,241,875,000	1,040,371,000	1,040,371,000	873,059,000	873,059,000	680,289,000	680,289,000	379,671,000	379,671,000	245,205,000	245,205,000	11,695,000
selling, general and administrative	31,622,000	25,014,000									17,344,500	22,638,000	26,043,000	20,697,000	22,727,000	17,221,000	20,056,000	17,413,000	17,121,000	13,899,000	13,670,000	14,350,000	15,721,000	16,666,000	16,609,000	25,673,000	17,976,000	19,394,000	21,731,000	20,618,000	23,278,000	17,725,000	18,566,000	15,389,000	15,333,000	13,135,000	11,110,000
gain on foreign currency transaction	5,363,000	2,509,000	131,500	2,454,000			2,776,000	-2,065,000	251,000	954,000
total expenses	71,228,000	56,061,000	50,281,000	57,319,000	55,776,000	49,541,000	50,614,000	46,156,000	46,890,000	46,624,000	48,849,000	42,435,000	39,348,000	33,248,000	36,483,000	28,801,000	33,553,000	23,627,000	42,190,000	24,482,000	23,029,000	23,356,000	27,345,000	23,374,000	25,954,000	30,962,000	23,762,000	26,012,000	24,430,000	30,254,000	33,367,000	30,222,000	33,734,000	22,611,000	24,237,000	44,125,000
income from operations	5,299,000	22,293,000	26,495,000	12,760,000	16,610,000	16,722,000	7,858,000	5,097,000	1,721,000	-5,998,000	-12,790,000	-9,610,000	-20,454,000	-21,256,000	-23,968,000	-6,590,000	-10,273,000	-6,191,000	-23,747,000	-9,130,000	-7,915,000	-7,121,000	-11,352,000	-8,779,000	-10,952,000	-13,514,000	-7,730,000	-21,543,000	-20,537,000	-26,789,000	-28,837,000	-28,179,000	-31,571,000	-19,602,000	-11,833,000	118,229,000	-19,124,000	-20,013,000	-272,863,000	-26,003,000	-24,051,000	-21,738,000	-30,103,000	-38,266,000	-69,846,000	-41,411,000	-2,107,882,000	-44,762,000	-41,585,000	-36,437,000	-1,947,791,000	-35,487,000	-44,054,000	-33,933,000	-1,804,345,000	-32,773,000	-1,811,767,000	-1,741,673,000	-1,741,673,000	-1,469,296,000	-1,469,296,000	-1,260,654,000	-1,260,654,000	-1,026,658,000	-1,026,658,000	-665,436,000	-665,436,000	-496,763,000	-496,763,000	-20,503,000	-18,382,000
yoy	-68.10%	33.32%	237.17%	150.34%	865.14%	-378.79%	-161.44%	-153.04%	-108.41%	-71.78%	-46.64%	45.83%	99.10%	243.34%	0.93%	-27.82%	29.79%	-13.06%	109.19%	4.00%	-27.73%	-47.31%	46.86%	-59.25%	-46.67%	-49.55%	-73.19%	-23.55%	-34.95%	36.66%	143.70%	-123.83%	65.09%	-2.05%	-95.66%	-554.67%	-20.49%	-7.94%	806.43%	-32.05%	-65.57%	-47.51%	-98.57%	-14.51%	67.96%	13.65%	8.22%	26.14%	-5.60%	7.38%	7.95%	8.28%	-97.57%	-98.05%	3.60%	-97.77%	23.31%	38.16%	38.16%	43.11%	43.11%	89.45%	89.45%	106.67%	106.67%	3520.04%	3520.04%
qoq	-76.23%	-15.86%	107.64%	-23.18%	-0.67%	112.80%	54.17%	196.17%	-128.69%	-53.10%	33.09%	-53.02%	-3.77%	-11.32%	263.70%	-35.85%	65.93%	-73.93%	160.10%	15.35%	11.15%	-37.27%	29.31%	-19.84%	-18.96%	74.83%	-64.12%	4.90%	-23.34%	-7.10%	2.34%	-10.74%	61.06%	65.66%	-110.01%	-718.22%	-4.44%	-92.67%	949.35%	8.12%	10.64%	-27.79%	-21.33%	-45.21%	68.67%	-98.04%	4609.09%	7.64%	14.13%	-98.13%	5388.75%	-19.45%	29.83%	-98.12%	5405.58%	-98.19%	4.02%	18.54%	18.54%	16.55%	16.55%	22.79%	22.79%	54.28%	54.28%	33.95%	33.95%	2322.88%	2322.88%	11.54%
operating margin %																																			-95.40%	72.82%
other income:																																																										38.16%	38.16%	43.11%	43.11%	89.45%	89.45%	106.67%	106.67%	3145.55%	3145.55%
interest income	1,832,000	1,956,000	2,825,000	3,179,000	3,177,000	3,434,000	1,725,000	1,580,000	1,547,000	1,302,000	957,000	663,000	516,000	377,000	48,000	36,000	25,000	3,000	2,000	18,000	14,000	133,000	203,000	220,000	255,000	318,000	196,000	144,000	55,000	106,000	115,000	65,000	58,000	55,000	15,000	28,000	26,000	15,000	10,000	2,000	3,000	3,000	5,000	1,000	1,000	1,000	37,000,000	2,000	1,000	1,000	36,994,000		1,000	1,000	36,971,000		36,986,000	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	275,000	123,000
interest expense	-285,000	-4,645,000	-1,562,000	-1,801,000	-6,051,000	-2,567,000	-2,677,000	-2,815,000	-6,873,000
interest expense on liability for sale of future royalties	-3,473,000	-3,577,000	-3,452,000	-4,089,000	-4,383,000	-4,248,000
interest expense on financing liability	-2,433,000	-2,410,000	-2,467,000	-2,470,000	-2,444,000	-2,447,000	-2,493,000	-2,459,000	-2,449,000	-2,424,000	-2,478,000	-2,466,000	-2,443,000	-2,371,000																																												36,953,000	36,953,000	36,892,000	36,892,000	35,875,000	35,875,000	26,736,000	26,736,000	11,629,000	11,629,000	6,448,000	6,448,000
loss on settlement of debt
loss on available-for-sale securities
total other income	-4,359,000	-8,676,000	-18,050,000	110,000	-18,301,000	-5,828,000	-4,896,000	-3,376,000	-6,986,000	-3,797,000	-5,157,000	-4,822,000	-8,569,000	-4,742,000	-4,093,000	2,164,000	-25,250,000	-6,725,000	-2,664,000	-2,343,000	-2,337,000	-2,201,000	-2,911,000	-1,591,000	-1,435,000	-1,369,000	-2,021,000	-2,625,000		-3,596,000	-3,896,000	-4,707,000	-3,768,000	3,278,000
income before income tax expense	940,000	13,617,000	8,445,000	12,870,000	-1,691,000	10,894,000	2,962,000	1,721,000	-5,265,000	-9,795,000
income tax expense	272,000	459,000	1,023,000	1,320,000	323,000	264,000																					-60,000		-240,000
net income	668,000	13,158,000	7,422,000	11,550,000	-2,014,000	10,630,000	1,401,000	1,721,000	-5,265,000	-9,795,000	-17,947,000	-14,432,000	-29,023,000	-25,998,000	-28,061,000	-4,426,000	-35,523,000	-12,916,000	-26,411,000	-11,255,000	-10,252,000	-9,322,000	-14,263,000	-10,370,000	-12,387,000	-14,883,000	-9,751,000	-24,168,000	-22,675,000	-30,385,000	-32,784,000	-32,886,000	-35,339,000	-16,324,000	53,974,000	126,520,000	-29,959,000	-24,873,000	-277,019,000	-31,857,000	-28,910,000	-30,658,000	-36,441,000	-36,520,000	-73,365,000	-52,056,000	-2,158,495,000	-50,818,000	-46,124,000	-40,965,000	-1,987,327,000	-42,834,000	-36,578,000	-38,173,000	-1,811,139,000	-38,402,000	-1,816,267,000													-20,188,000	-18,245,000
yoy	-133.17%	23.78%	429.76%	571.12%	-61.75%	-208.52%	-107.81%	-111.92%	-81.86%	-62.32%	-36.04%	226.07%	-18.30%	101.29%	6.25%	-60.68%	246.50%	38.55%	85.17%	8.53%	-17.24%	-37.36%	46.27%	-57.09%	-45.37%	-51.02%	-70.26%	-26.51%	-35.84%	86.14%	-160.74%	-125.99%	17.96%	-34.37%	-119.48%	-497.15%	3.63%	-18.87%	660.18%	-12.77%	-60.59%	-41.11%	-98.31%	-28.14%	59.06%	27.07%	8.61%	18.64%	26.10%	7.31%	9.73%	11.54%	-97.99%	-97.80%	4.30%	-97.34%	25.82%	40.91%	40.91%	43.48%	43.48%	87.96%	87.96%	104.36%	104.36%	3493.37%	3493.37%
qoq	-94.92%	77.28%	-35.74%	-673.49%	-118.95%	658.74%	-18.59%	-132.69%	-46.25%	-45.42%	24.36%	-50.27%	11.64%	-7.35%	534.00%	-87.54%	175.03%	-51.10%	134.66%	9.78%	9.98%	-34.64%	37.54%	-16.28%	-16.77%	52.63%	-59.65%	6.58%	-25.37%	-7.32%	-0.31%	-6.94%	116.48%	-130.24%	-57.34%	-522.31%	20.45%	-91.02%	769.57%	10.19%	-5.70%	-15.87%	-0.22%	-50.22%	40.93%	-97.59%	4147.50%	10.18%	12.59%	-97.94%	4539.60%	17.10%	-4.18%	-97.89%	4616.26%	-97.89%	4.60%	20.29%	20.29%	17.14%	17.14%	22.49%	22.49%	53.45%	53.45%	33.18%	33.18%	2338.48%	2338.48%	10.65%
net income margin %																																			435.13%	77.93%
net income per share	0	0.04	0.03	0.04	-0.01	0.04	0.01	0.01	-0.02	-0.04	-0.07	-0.06	-0.11	-0.1	-0.11	-0.02	-0.14	-0.05	-0.12	-0.05	-0.05	-0.04	-0.07	-0.05	-0.07	-0.08	-0.04	-0.16	-0.16	-0.25	-0.29	-0.31	-0.35	-0.17	1.21	0.26	-0.07	-0.06	-0.68	-0.08	-0.07	-0.08	-0.09	-0.09	-0.19	-0.14	-0.12	-0.17	-0.16	-0.15	-0.178	-0.22	-0.23	-0.27	-0.255	-0.31
weighted-average shares used for eps calculation	304,954	303,481	274,415	274,998	273,056	270,356	267,014	268,732	265,626
net revenue – commercial product sales			14,818,000	19,728,000	20,780,000	18,764,000	20,195,000	17,927,000	18,345,000	17,562,000																																																-1,736,436,000	-1,736,436,000	-1,443,490,000	-1,443,490,000	-1,232,286,000	-1,232,286,000	-1,006,026,000	-1,006,026,000	-655,611,000	-655,611,000	-492,280,000	-492,280,000
revenue – collaborations and services			18,532,500	23,268,000	26,014,000	24,848,000	17,249,000	13,108,000	11,211,000	11,386,000																																																40.91%	40.91%	43.48%	43.48%	87.96%	87.96%	104.36%	104.36%	3147.53%	3147.53%
royalties – collaboration			18,831,500	27,083,000	25,592,000																																																					0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
cost of goods sold			4,808,000	3,197,000	5,605,000	3,819,000	6,114,000	3,995,000	5,224,000	5,530,000	4,081,000	5,021,000	4,617,000	2,284,000	4,295,000	3,812,000	4,411,000	4,315,000	3,652,000	3,591,000	3,677,000	4,164,000	4,632,000	7,099,000	4,327,000	4,020,000	4,996,000	5,303,000	5,095,000	4,008,000	5,018,000	4,575,000	5,086,000	2,548,000	1,554,000	4,331,000
selling			9,047,250	13,093,000	11,495,000	11,601,000	11,024,000	13,440,000	14,002,000	13,310,000
general and administrative			8,542,000	10,823,000	12,617,000	10,728,000	9,511,000	10,538,000	11,947,000	10,542,000																												7,351,000	8,311,000	11,547,000	10,623,000	10,479,000	12,543,000	19,088,000	32,523,000	15,229,000	443,333,000	17,481,000	14,533,000	10,039,000	388,442,000	10,069,000	17,416,000	9,777,000	349,938,000	9,641,000	351,363,000													8,808,000
gain on bargain purchase				5,259,000
other income				32,000			-164,000	318,000	-143,000	111,000	105,000	-207,000			1,000	1,000	35,000	-276,000	-1,000	14,000	14,000	-4,000	-842,000	-52,000	-17,000	-14,000	-508,000	10,000	30,000	31,000				14,000	16,000	-27,000	-5,959,000	67,000	-104,000	67,000	-10,000	1,413,000	41,000	7,898,000	-370,000	-5,890,000	-2,950,000	10,000	15,000	23,000	-14,345,000	-2,651,000	13,347,000	1,382,000	-2,552,000	79,000	-1,267,000													40,000	14,000
loss on extinguishment of debt			-1,762,500		-7,050,000												-22,130,000										-191,250	-712,000		-825,000	-207,500		-830,000							-1,049,000
gain on available-for-sale securities			-387,500		-1,550,000		233,000		932,000
(gain) loss on foreign currency transaction					-529,000	-1,399,000
royalties – collaborations						22,651,000	21,028,000	20,218,000	19,055,000	11,678,000																																																331,725,000	331,725,000	260,759,000	260,759,000	219,429,000	219,429,000	178,183,000	178,183,000	117,569,000	117,569,000	83,262,000	83,262,000
benefit from income taxes
interest expense on notes										-2,786,000	-2,809,000	-2,812,000	-6,642,000	-2,748,000	-4,261,000	-2,709,000	-2,812,000	-5,422,000	-1,104,000	-1,057,000	-1,084,000	-1,071,000	-1,021,000	-4,126,000	-564,000	-593,000	-620,000	-993,000	-1,709,000	-1,794,000	-2,056,000	-2,310,000	-2,422,000	-2,706,000	-3,009,000	-4,166,000	-4,181,000	-4,221,000	-3,332,000	-4,145,000	-4,131,000	-9,622,000	-5,654,000	-5,424,000	-2,429,000	-4,042,000												-1,990,000	-1,990,000	-1,872,000	-1,872,000	-1,881,000	-1,881,000	-1,526,000	-1,526,000	-1,783,000	-1,783,000	-1,949,000	-1,949,000
shares used to compute net income per share – basic and diluted										263,969
net revenue — commercial product sales											17,440,000	16,259,000	12,722,000	9,826,000	11,340,000	9,753,000	9,976,000	8,099,000	10,064,000	7,275,000	6,985,000	8,000,000
revenue — collaborations and services											9,544,000	10,346,000	5,868,000	2,166,000	1,175,000	12,458,000	13,304,000	9,337,000	8,379,000	8,077,000	8,129,000	8,235,000
royalties — collaborations											9,075,000	6,220,000
cost of revenue — collaborations and services											12,043,000	12,439,000	8,298,000	8,714,000	7,139,000	6,075,000	5,515,000	3,295,000	2,631,000	1,581,000	1,983,000	3,362,000
asset impairment															26,500	106,000			472,250		368,000
gain on foreign currency translation											-2,071,250	-1,799,000		-1,983,000			903,000	-3,838,000	4,008,000	3,927,000	1,867,000	-1,796,000	2,582,000	-3,807,000
loss on purchase commitments																	339,000
gain on extinguishment of debt															-4,300,000	4,930,000								3,529,000					772,000
income before benefit from income taxes											-17,363,250	-14,432,000	-29,023,000	-25,998,000	-13,216,250	-4,426,000	-35,523,000	-12,916,000	-7,761,750	-11,473,000	-10,252,000	-9,322,000	-9,410,000	-10,370,000	-12,387,000	-14,883,000	-19,246,000	-24,168,000	-22,435,000	-30,385,000																					-29,498,250	-43,242,000	-36,578,000	-38,173,000	-1,811,113,000	-38,402,000	-1,816,241,000													-20,188,000	-18,245,000
shares used to compute net income per share - basic and diluted											63,743.5	259,300	253,644	251,887	62,156	249,910
(gain) loss on foreign currency translation													-4,503,000		-1,564,000	-2,068,000									1,247,000	-1,935,000	-1,361,000	-728,000	-5,363,000				6,848,000
interest expense on mann group promissory notes															-373,000	-94,000	-368,000	-1,030,000
shares used to compute basic and diluted net income per share																	249,295	246,631	54,639.75	229,668	213,880	212,467	47,946.5	199,906	188,054	187,434	34,576.75	153,597	140,054	120,911			99,864	95,744			455,305	428,858	4,431	405,199	401,018	398,916
interest expense on promissory notes																			-1,297,000	-1,318,000	-1,281,000	-1,259,000	-1,251,000	-1,162,000
benefit for income taxes																			54,500	218,000																																						-1,736,410,000	-1,736,410,000	-1,443,464,000	-1,443,464,000	-1,232,262,000	-1,232,262,000	-1,006,005,000	-1,006,005,000	-655,590,000	-655,590,000	-492,264,000	-492,264,000
impairment of commitment asset																						1,521,000
net revenue - commercial product sales																							4,385,750	6,402,000	6,065,000	5,076,000	5,734,000	4,387,000	3,753,000	3,402,000	4,466,000	1,981,000		1,196,000	143,250	573,000
revenue - collaborations and services																							7,375,500	8,193,000	8,937,000	12,372,000
revenue - other																											13,250		53,000		1,000
cost of revenue - collaborations and services																							1,378,000	1,836,000	2,139,000	1,537,000
interest expense on note payable to related party																									-1,109,000	-1,080,000	-1,089,000	-1,074,000	-1,046,000	-1,114,000																	-1,280,750	-1,745,000	-1,689,000	-1,689,000	-30,504,000	-2,245,000	-3,028,000	-3,048,000	-20,485,000	-2,863,000	-19,927,000
net revenue - collaborations																											58,000	82,000
property and equipment impairment																																92,000	111,000
gain on purchase commitments
change in fair value of warrant liability																																-1,289,000	147,000	6,629,000	-2,510,000	13,185,000
net revenue - collaboration																													87,000	63,000	63,000	62,000		63,000	40,445,250	161,781,000
total other																													-1,898,000																													-14,678,000	-14,678,000	-2,116,000	-2,116,000
loss on foreign currency translation																														2,984,000	3,019,250	3,684,000		1,545,000
product costs - collaboration																																			5,685,500	22,742,000
gain on purchase commitment																															-53,750	-215,000
interest expense on note payable to principal stockholder																															-1,174,000	-1,173,000	-721,000	-714,000			-721,000	-721,000	-730,000	-729,000	-721,000	-714,000	-730,000	-729,000	-721,000	-714,000
income before benefit for income taxes																															-21,137,250	-32,886,000	-35,339,000	-16,324,000				-24,873,000	-277,019,000	-31,857,000	-28,910,000	-30,658,000	-36,441,000	-36,520,000	-73,365,000	-52,056,000	-2,158,877,000	-50,818,000	-46,124,000	-40,965,000
income tax benefit																																																			26,000	-408,000
shares used to compute basic net income per share																															4,109	104,703			-362,135	478,137
shares used to compute diluted net income per share																															4,109	104,703			-362,281	482,744
net revenue—commercial product sales																																	1,548,000
net revenue—collaboration																																	63,000																													-1,511,000	-1,511,000	-1,511,000	-1,511,000
revenue—other																																	552,000
revenue - bulk insulin sales																																		1,750,000
revenue:
total net revenue																																			12,404,000	162,354,000
yoy
qoq																																			-92.36%
expense:
interest expense on note payable to our principal stockholder																																			-543,000	-729,000
income before income tax benefit																																			17,922,500	126,520,000
revenue																																																			3,131,000	35,000			3,081,000		3,131,000
operating expenses:
product manufacturing																																					3,704,000	7,532,000	51,754,000	8,115,000	5,691,000	1,882,000
total operating expenses																																					19,124,000	20,013,000	272,863,000	26,003,000	24,051,000	21,738,000	30,103,000	38,266,000	69,846,000	41,411,000	2,111,048,000	44,762,000	41,585,000	36,437,000	1,950,922,000	35,522,000	44,054,000	33,933,000	1,807,426,000	32,773,000	1,814,898,000													20,503,000	18,382,000
in-process research and development costs																																																									19,726,000
goodwill impairment																																																									151,428,000
deemed dividend related to beneficial conversion feature of convertible preferred stock																																																									-22,260,000													-19,210,000
accretion on redeemable preferred stock																																																									-952,000														4,000
net income applicable to common stockholders																																											-40,485,250	-36,520,000	-73,365,000	-52,056,000	-2,181,707,000	-50,818,000	-46,124,000	-40,965,000	-2,010,539,000	-42,834,000	-36,578,000	-38,173,000	-1,834,351,000	-38,402,000	-1,839,479,000	3,081,000	3,081,000	2,988,000	2,988,000	2,988,000	2,988,000	2,968,000	2,968,000	2,958,000	2,958,000	2,858,000	2,858,000	-39,398,000	-18,241,000
shares used to compute basic and diluted net income per share applicable to common stockholders																																											95,333	394,163	380,770	368,784	71,722.25	296,386	284,044	280,058	41,152.75	190,534	159,859	143,154	30,409	122,130
interest expense on senior convertible notes and facility financing obligation																																															-2,513,000	-4,323,000
interest expense on senior convertible notes																																																	-2,866,000	-2,863,000	-31,655,000	-2,859,000	-2,844,000	-2,575,000	-20,702,000	-2,845,000	-20,266,000	1,744,754,000	1,744,754,000	1,472,284,000	1,472,284,000	1,263,642,000	1,263,642,000	1,029,626,000	1,029,626,000	668,394,000	668,394,000	499,621,000	499,621,000
income taxes																																																									-26,000	19,726,000	19,726,000			19,726,000	19,726,000	19,726,000	19,726,000	19,726,000	19,726,000	19,726,000	19,726,000
in—process research and development costs																																																										151,428,000	151,428,000	151,428,000	151,428,000	151,428,000	151,428,000	151,428,000	151,428,000	151,428,000	151,428,000	151,428,000	151,428,000
income tax provision																																																										-22,260,000	-22,260,000	-22,260,000	-22,260,000	-22,260,000	-22,260,000	-22,260,000	-22,260,000	-22,260,000	-22,260,000	-22,260,000	-22,260,000
net income per share	0	0.04	0.03	0.04	-0.01	0.04	0.01	0.01	-0.02	-0.04	-0.07	-0.06	-0.11	-0.1	-0.11	-0.02	-0.14	-0.05	-0.12	-0.05	-0.05	-0.04	-0.07	-0.05	-0.07	-0.08	-0.04	-0.16	-0.16	-0.25	-0.29	-0.31	-0.35	-0.17	1.21	0.26	-0.07	-0.06	-0.68	-0.08	-0.07	-0.08	-0.09	-0.09	-0.19	-0.14	-0.12	-0.17	-0.16	-0.15	-0.178	-0.22	-0.23	-0.27	-0.255	-0.31		-952,000	-952,000	-952,000	-952,000	-952,000	-952,000	-952,000	-952,000	-952,000	-952,000	-952,000	-952,000
basic and diluted																																																										-1,759,648,000	-1,759,648,000	-1,466,702,000	-1,466,702,000	-1,255,498,000	-1,255,498,000	-1,029,238,000	-1,029,238,000	-678,823,000	-678,823,000	-515,492,000	-515,492,000	-1.4	-0.91
shares used to compute basic and diluted net income per share:
basic and diluted																																																																						28,051	19,975
research & development																																																										-15,022,000	-15,022,000	-7,072,000	-7,072,000	-4,091,000	-4,091,000	-3,046,000	-3,046,000						14,311,000
general & administrative																																																										-26,000	-26,000	-26,000	-26,000	-24,000	-24,000	-21,000	-21,000	-21,000	-21,000	-16,000	-16,000		4,071,000
basic and diluted – pro forma																																																												19,726,000	19,726,000										-0.73
shares used to compute net income per share:
basic and diluted																																																																						28,051	19,975

We provide you with 20 years income statements for MannKind stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MannKind stock. Explore the full financial landscape of MannKind stock with our expertly curated income statements.

The information provided in this report about MannKind stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.